scholarly article | Q13442814 |
P50 | author | Jessica A Sipkens | Q130284857 |
P2093 | author name string | Suat Simsek | |
Floris P van Alphen | |||
Victor W M van Hinsbergh | |||
Casper G Schalkwijk | |||
Jaap D van Buul | |||
Hans W M Niessen | |||
Ivana Kholová | |||
Paul A J Krijnen | |||
Christof Meischl | |||
Alexander B A Vonk | |||
Nynke E Hahn | |||
Umit Baylan | |||
P2860 | cites work | Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders | Q28116286 |
Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins | Q28507544 | ||
Thrombopoietin modulates cardiac contractility in vitro and contributes to myocardial depressing activity of septic shock serum | Q28581675 | ||
The many faces of tissue factor | Q33711050 | ||
Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice | Q33750640 | ||
Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. | Q34299156 | ||
No-reflow phenomenon | Q34517875 | ||
Neuropeptide Y: a novel mechanism for ischemic angiogenesis | Q35066249 | ||
Tissue factor and thrombin mediate myocardial ischemia-reperfusion injury | Q35073959 | ||
The multifunctional or moonlighting protein CD26/DPPIV. | Q35089114 | ||
Effect of PAR2 in regulating TNF-α and NAD(P)H oxidase in coronary arterioles in type 2 diabetic mice | Q35128047 | ||
No-reflow phenomenon and prognosis in patients with acute myocardial infarction | Q36577567 | ||
Imaging microvascular obstruction and its clinical significance following acute myocardial infarction | Q36666471 | ||
Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action | Q36751470 | ||
Integrin alpha(v)beta(3) on human endothelial cells binds von Willebrand factor strings under fluid shear stress | Q37100768 | ||
Coronary microembolization: from bedside to bench and back to bedside | Q37626321 | ||
TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure | Q37771751 | ||
Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach | Q37774756 | ||
The role of endothelial interleukin-8/NADPH oxidase 1 axis in sepsis | Q39697418 | ||
Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles | Q39774393 | ||
Direct relationship between levels of TNF-alpha expression and endothelial dysfunction in reperfusion injury | Q40358563 | ||
Alterations in tumor necrosis factor-induced endothelial cell procoagulant activity by hyperthermia | Q40540907 | ||
Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. | Q40918403 | ||
Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. | Q42138675 | ||
Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways | Q42165735 | ||
Mitochondrial reactive oxygen species: a common pathway for PAR1- and PAR2-mediated tissue factor induction in human endothelial cells | Q42602246 | ||
Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A. | Q43071459 | ||
The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA. | Q43140566 | ||
Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth fac | Q43245112 | ||
Blockade of NF-kappaB by pyrrolidine dithiocarbamate attenuates myocardial inflammatory response and ventricular dysfunction following coronary microembolization induced by homologous microthrombi in rats | Q43262789 | ||
Coronary occlusion: cause or consequence of acute myocardial infarction? | Q44827749 | ||
Antagonism of selectin function attenuates microvascular platelet deposition and platelet-mediated myocardial injury after transient ischemia | Q45226110 | ||
Inhibition of dipeptidyl peptidase 4 regulates microvascular endothelial growth induced by inflammatory cytokines | Q45721715 | ||
Guggulsterone, an anti-inflammatory phytosterol, inhibits tissue factor and arterial thrombosis | Q46294089 | ||
Exogenous superoxide mediates pro-oxidative, proinflammatory, and procoagulatory changes in primary endothelial cell cultures | Q46743274 | ||
The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the multicenter AMICI study. | Q46780250 | ||
Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits | Q47241260 | ||
Different enzyme activities in coronary capillary endothelial cells. | Q50532021 | ||
PDGF-CC induces tissue factor expression: role of PDGF receptor alpha/beta. | Q54462813 | ||
Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-diabetic rats. | Q54632091 | ||
Thrombogenicity of vascular cells. Comparison between endothelial cells isolated from different sources and smooth muscle cells and fibroblasts | Q68795347 | ||
A negative blood-clotting factor lining the vessels | Q70241658 | ||
Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion | Q70908026 | ||
Dipeptidyl peptidase IV inhibits the polymerization of fibrin monomers | Q71451365 | ||
C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction | Q71971756 | ||
Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets | Q73281199 | ||
F11-receptor (F11R/JAM) mediates platelet adhesion to endothelial cells: role in inflammatory thrombosis | Q78505148 | ||
Differential functions of tissue factor in the trans-activation of cellular signalling pathways | Q79396021 | ||
N(epsilon)-(carboxymethyl)lysine depositions in intramyocardial blood vessels in human and rat acute myocardial infarction: a predictor or reflection of infarction? | Q80265058 | ||
Microparticles from apoptotic monocytes induce transient platelet recruitment and tissue factor expression by cultured human vascular endothelial cells via a redox-sensitive mechanism | Q81445961 | ||
Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation | Q83022905 | ||
The basement membrane of intramyocardial capillaries is thickened in patients with acute myocardial infarction | Q84388623 | ||
DPP4 deficiency preserves cardiac function via GLP-1 signaling in rats subjected to myocardial ischemia/reperfusion | Q84543059 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endothelium | Q111140 |
P304 | page(s) | 233 | |
P577 | publication date | 2011-12-14 | |
P1433 | published in | Basic Research in Cardiology | Q2453360 |
P1476 | title | Loss of DPP4 activity is related to a prothrombogenic status of endothelial cells: implications for the coronary microvasculature of myocardial infarction patients | |
P478 | volume | 107 |
Q39337755 | Activated platelet chemiluminescence and presence of CD45+ platelets in patients with acute myocardial infarction. |
Q38195527 | Antiatherothrombotic effects of dipeptidyl peptidase inhibitors |
Q47258313 | Cardioprotection--time to take into account clinical complexity: the case of antiplatelet agents : editorial to "two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts" by Xi-Ming Yang et al. |
Q37611715 | Cardiovascular Benefits of Native GLP-1 and its Metabolites: An Indicator for GLP-1-Therapy Strategies |
Q34383575 | Cardiovascular impact of drugs used in the treatment of diabetes |
Q48254834 | DPP-4 inhibitors repress NLRP3 inflammasome and interleukin-1beta via GLP-1 receptor in macrophages through protein kinase C pathway |
Q39040954 | DPP-4 inhibitors repress foam cell formation by inhibiting scavenger receptors through protein kinase C pathway |
Q38413395 | DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition. |
Q38118157 | Dipeptidyl peptidase-4 inhibitors and their effects on the cardiovascular system |
Q45897317 | Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis. |
Q37065219 | Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus |
Q52356627 | Infectious myocarditis: the role of the cardiac vasculature. |
Q94950741 | Is DPP4 inhibition a comrade or adversary in COVID-19 Infection |
Q28084374 | Mononuclear cells and vascular repair in HHT |
Q37522403 | Plasma DPP4 activity is associated with no-reflow and major bleeding events in Chinese PCI-treated STEMI patients |
Q41094907 | Plasma dipeptidyl-peptidase-4 activity is associated with left ventricular systolic function in patients with ST-segment elevation myocardial infarction |
Q48136973 | Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors. |
Q58797884 | Reduced post-operative DPP4 activity associated with worse patient outcome after cardiac surgery |
Q34029715 | The nonglycemic actions of dipeptidyl peptidase-4 inhibitors |
Q38121545 | The role of DPP4 activity in cardiovascular districts: in vivo and in vitro evidence |